A
Anteris Technologies Global Corp. (AVR)
NGM – Real Time Price. Currency in USD
6.70
+0.19 (2.92%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
6.70
+0.19 (2.92%)
At close: May 12, 2026, 4:00 PM EDT
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
There is no data to display
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | 8-K | ef20071159_8k.htm |
| 2026-04-23 | 8-K | ef20070365_8k.htm |
| 2026-03-10 | POS AM | ny20067285x1_posam.htm |
| 2026-03-03 | 8-K | ef20067006_8k.htm |
| 2026-02-27 | 8-K | ef20066524_8k.htm |
| 2026-02-26 | 10-K | ef20060646_10k.htm |
| 2026-01-22 | 8-K | ny20062007x8_8k.htm |
| 2026-01-02 | S-3 | ny20062007x1_s3.htm |
| 2025-12-15 | 8-K | ef20061219_8k.htm |
| 2025-12-04 | 8-K | ef20060245_8k.htm |